We present a patient who has been diagnosed with Hypereosinophilic
syndrome, later determined to be chronic eosinophilic leukemia, after
long-term treatment with infliximab for ulcerative colitis. Follow-up
immunochemistry showed that discontinuation of infliximab improved the
polyclonality of eosinophils in our patient.